Domain EYEION.com for sale! This premium domain is available now at Kadomain.com
An acupuncturist explains how this scary-looking acupressure mat can help relieve back pain.View Entire Post ›
One in four Australian adults have at least one tattoo, but new research suggests that what's in the ink may pose greater risks than the size and design of the tattoo.
Four out of five parents tell their donor-conceived children about their biological origins, according to new research out of Waipapa Taumata Rau, University of Auckland.
Every movement we make, whether walking, speaking or even breathing, depends on the health of our muscles and nerves.
Dyslexia is a neurodevelopmental condition estimated to affect between 5–10% of people living in most countries, irrespective of their educational and cultural background. Dyslexic individuals experience persistent difficulties with reading and writing, often struggling to identify words and spell them correctly.
The Congressional Budget Office has estimated that permanently extending premium health subsidies would increase the number of insured people to 3.8 million by 2035 while also increasing the deficit by $349.8 billion over 10 years.
A Novo Nordisk-designed trial, conducted at 68 international hospitals, specialist clinics, and medical centers with investigators from University of Texas Southwestern Medical Center and other institutions, reports greater reductions with once-weekly semaglutide 7.2 mg than placebo in bodyweight, waist circumference, and HbA1c over 72 weeks.
On September 18th, the Centers for Disease Control and Prevention's vaccine advisory committee voted to make a significant change to the nation's childhood vaccine schedule during its first gathering since members were handpicked by Health and Human Services Secretary Robert F. Kennedy Jr.
The American Gastroenterological Association (AGA) has released a new clinical guideline with 12 conditional recommendations for diagnosing and managing gastroparesis, a serious and often debilitating disease. The guideline has been published in the journal Gastroenterology.
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible biomarkers that could guide the development of more personalized therapies for pediatric germ cell tumors (GCTs).
A US medical panel handpicked by President Donald Trump's health secretary made its first alteration to the standard childhood vaccine schedule on Thursday, as public health experts fear more changes that flout prevailing medical advice are in the pipeline.
Scientists have developed and tested a deep-learning model that could support clinicians by providing accurate results and clear, explainable insights—including a model-estimated probability score for autism.
The largest study on pregnant women with excessive nausea and vomiting (hyperemesis gravidarum) has identified increased risks of numerous neuropsychiatric and mental health outcomes. The study is published in the journal The Lancet Obstetrics, Gynaecology, & Women's Health.
The current process for managing sexual misconduct perpetrated by doctors in the UK requires major reform, say experts in The BMJ.
New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10–17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both.
The global type 1 diabetes (T1D) burden continues to increase rapidly, driven by rising cases, aging populations, improved diagnosis and falling death rates, according to the results of a new modeling study presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), Vienna (15–19 Sept).
New research (the Ver-A-T1D trial) presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15–19 September) shows that slow-release (SR) verapamil (360mg daily) could have a potential effect on beta-cell function in adults with newly diagnosed type 1 diabetes.
In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition.
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.